2006 Doctors Drugs Pharmacy 
Drug Channels
APRIL 26, 2022
Glaucomflecken helps UnitedHealthcare celebrate Doctors’ Day! Next week, I'll be live and in-person at Asembia's Specialty Pharmacy Summit. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.
Drug Channels
SEPTEMBER 19, 2023
Today, the House Committee on Oversight and Accountability will hold a hearing with a subtle and not-at-all pejorative title: The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part II: Not What the Doctor Ordered. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
NOVEMBER 24, 2020
In this issue: Rebate rule redux Most Favored Nation and healthcare benchmarking Amazon’s pharmacy customer opportunity Drug spending realities updated GPO consolidation Plus, I congratulate Dirk Rodgers of RxTrace on his retirement. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.
Agency IQ
SEPTEMBER 15, 2023
FDA’s nonprescription advisors find no efficacy for phenylephrine This week, FDA’s Nonprescription Drugs Advisory Committee (NDAC) voted unanimously that current scientific data do not support the efficacy of oral phenylephrine as a nasal decongestant, aligning with FDA analysis — and re-analysis — of data.
Drug & Device Law
FEBRUARY 10, 2023
That issue, in turn, involves product identification (another problem in MDLs) and a pointer for pharmacies that want to avoid being involved in pharmaceutical litigation. That manufacturer had relinquished all of its rights to Zantac in December 2006 – eight years before plaintiff began using it in 2014. Boehringer Ingelheim Pharms.,
Expert insights. Personalized for you.
98 
Let's personalize your content